| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cytokinetics, Incorporated (CYTK) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. CYTK is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 400.3K | $32.57M | - | |
| VP | 157.4K | $12.81M | -3,500 | |
| CFO | 100.8K | $8.21M | - | |
| Other | 87.3K | $7.10M | - | |
| VP | 58.6K | $4.76M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 1, 2025 | Harrington Robert Arthur51 | Director | Sell | 2,150 | $66.80 | $143,620.00 | -10.4% | -6.9% | - | |
| Nov 19, 2025 | Parshall B Lynne74 | Director | Sell | 5,000 | $64.73 | $323,650.00 | -17.9% | +2.8% | - | |
| Nov 18, 2025 | Malik Fady Ibraham55 | EVP Research &Development | Sale+OE | 2,200 | $66.45 | $146,190.00 | -1.5% | +0.7% | - | |
| Nov 11, 2025 | Kaye Edward M. Md46 | Director | Sale+OE | 5,175 | $65.08 | $336,789.00 | -34.2% | -4.7% | - | |
| Nov 4, 2025 | Malik Fady Ibraham55 | EVP Research &Development | Sale+OE | 2,295 | $59.55 | $136,667.25 | -1.6% | +9.3% | - | |
| Oct 30, 2025 | Blum Robert I50 | President &CEO | Sell | 5,000 | $62.86 | $314,300.00 | -1.4% | +4.6% | - | |
| Oct 27, 2025 | Wierenga Wendell | Director | Sale+OE | 4,375 | $58.68 | $256,725.00 | -11.9% | +5.0% | - | |
| Oct 21, 2025 | Malik Fady Ibraham55 | EVP Research &Development | Sale+OE | 2,105 | $58.22 | $122,553.10 | -1.5% | +10.4% | - | |
| Oct 16, 2025 | Blum Robert I50 | President &CEO | Sell | 5,000 | $60.03 | $300,150.00 | -1.4% | +9.6% | - | |
| Oct 7, 2025 | Malik Fady Ibraham55 | EVP Research &Development | Sale+OE | 2,000 | $60.56 | $121,120.00 | -1.4% | +1.8% | - |